$415 Million is the total value of Sio Capital Management, LLC's 71 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 128.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACAD | New | ACADIA PHARMACEUTICALS INCput | $54,949,000 | – | 2,055,700 | +100.0% | 13.25% | – |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $21,405,000 | +104.2% | 124,164 | +99.7% | 5.16% | +82.4% |
| HCA | Buy | HCA HEALTHCARE INC | $21,247,000 | +51.7% | 157,184 | +46.3% | 5.12% | +35.5% |
| WCG | Buy | WELLCARE HEALTH PLANS INC | $17,815,000 | +207.7% | 62,495 | +191.2% | 4.30% | +174.8% |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $15,188,000 | +38.7% | 379,500 | +44.8% | 3.66% | +23.9% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $13,936,000 | +234.8% | 135,300 | +138.2% | 3.36% | +198.9% |
| MEDP | Buy | MEDPACE HOLDINGS INC | $12,156,000 | +13.3% | 185,815 | +2.2% | 2.93% | +1.2% |
| LJPC | New | LA JOLLA PHARMACEUTICAL CO | $12,121,000 | – | 1,310,367 | +100.0% | 2.92% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $10,997,000 | +48.7% | 151,553 | +91.5% | 2.65% | +32.7% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $9,368,000 | +95.7% | 71,521 | +101.9% | 2.26% | +74.7% |
| MRK | New | MERCK & CO INCput | $8,385,000 | – | 100,000 | +100.0% | 2.02% | – |
| NVS | New | NOVARTIS AGsponsored adr | $8,297,000 | – | 90,870 | +100.0% | 2.00% | – |
| ANTM | New | ANTHEM INC | $8,280,000 | – | 29,339 | +100.0% | 2.00% | – |
| CERN | New | CERNER CORPput | $7,990,000 | – | 109,000 | +100.0% | 1.93% | – |
| ITCI | New | INTRA-CELLULAR THERAPIES INCput | $7,889,000 | – | 607,800 | +100.0% | 1.90% | – |
| HUM | Buy | HUMANA INC | $7,510,000 | +161.0% | 28,307 | +161.7% | 1.81% | +133.1% |
| BEAT | New | BIOTELEMETRY INC | $7,413,000 | – | 153,955 | +100.0% | 1.79% | – |
| UNH | Buy | UNITEDHEALTH GROUP INC | $7,119,000 | +86.9% | 29,176 | +89.4% | 1.72% | +66.8% |
| UTHR | Buy | UNITED THERAPEUTICS CORP | $6,471,000 | +63.8% | 82,892 | +146.3% | 1.56% | +46.3% |
| SYNH | Buy | SYNEOS HEALTH INCcl a | $6,432,000 | +51.7% | 125,899 | +53.7% | 1.55% | +35.5% |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $5,236,000 | +30.5% | 403,664 | +58.6% | 1.26% | +16.5% |
| SPPI | Buy | SPECTRUM PHARMACEUTICALS INC | $5,201,000 | -12.2% | 604,019 | +9.0% | 1.25% | -21.6% |
| ICLR | Buy | ICON PLC | $4,701,000 | +53.2% | 30,530 | +35.9% | 1.13% | +36.7% |
| ITGR | New | INTEGER HOLDINGS CORP | $4,686,000 | – | 55,844 | +100.0% | 1.13% | – |
| HRC | Buy | HILL-ROM HOLDINGS INC | $4,413,000 | +330.5% | 42,182 | +335.7% | 1.06% | +284.1% |
| AVTR | New | AVANTOR INC | $4,230,000 | – | 221,587 | +100.0% | 1.02% | – |
| UBER | New | UBER TECHNOLOGIES INC | $4,174,000 | – | 90,000 | +100.0% | 1.01% | – |
| CHRS | New | COHERUS BIOSCIENCES INC | $4,074,000 | – | 184,366 | +100.0% | 0.98% | – |
| NTRA | New | NATERA INC | $4,013,000 | – | 145,500 | +100.0% | 0.97% | – |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $3,842,000 | +0.3% | 32,630 | +8.8% | 0.93% | -10.4% |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $3,792,000 | +2.9% | 514,544 | +13.3% | 0.91% | -8.1% |
| HSACU | New | HEALTH SCIENCES ACQUISITIONS CORP | $3,255,000 | – | 307,000 | +100.0% | 0.78% | – |
| CCRN | New | CROSS COUNTRY HEALTHCARE INC | $2,427,000 | – | 258,727 | +100.0% | 0.58% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $1,982,000 | – | 522,863 | +100.0% | 0.48% | – |
| DOVA | New | DOVA PHARMACEUTICALS INC | $1,905,000 | – | 135,133 | +100.0% | 0.46% | – |
| UROV | Buy | UROVANT SCIENCES LTD | $1,741,000 | -19.4% | 220,042 | +2.3% | 0.42% | -28.0% |
| ACHC | New | ACADIA HEALTHCARE COMPANY INCput | $1,342,000 | – | 38,400 | +100.0% | 0.32% | – |
| GLYC | New | GLYCOMIMETICS INCput | $1,312,000 | – | 110,100 | +100.0% | 0.32% | – |
| WST | New | WEST PHARMACEUTICAL SERVICES INCput | $1,239,000 | – | 9,900 | +100.0% | 0.30% | – |
| ATNM | Buy | ACTINIUM PHARMACEUTICALS INC | $1,214,000 | +644.8% | 4,935,250 | +1352.4% | 0.29% | +565.9% |
| ACHV | Buy | ACHIEVE LIFE SCIENCES INC | $1,012,000 | -25.6% | 524,413 | +24.4% | 0.24% | -33.5% |
| SVRA | New | SAVARA INCput | $982,000 | – | 414,400 | +100.0% | 0.24% | – |
| IMMU | New | IMMUNOMEDICS INC | $971,000 | – | 70,000 | +100.0% | 0.23% | – |
| UBX | New | UNITY BIOTECHNOLOGY INC | $956,000 | – | 100,635 | +100.0% | 0.23% | – |
| SVRA | New | SAVARA INC | $948,000 | – | 400,000 | +100.0% | 0.23% | – |
| CCXI | New | CHEMOCENTRYX INCcall | $930,000 | – | 100,000 | +100.0% | 0.22% | – |
| OCUL | New | OCULAR THERAPEUTIX INC | $263,000 | – | 59,668 | +100.0% | 0.06% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INCput | $147,000 | – | 38,700 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS ORD | 24 | Q4 2023 | 8.3% |
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 19 | Q1 2024 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| THE CIGNA GROUP | 17 | Q2 2024 | 11.0% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 14, 2024 | 280,000 | 7.5% |
| Gracell Biotechnologies Inc. | February 14, 2024 | 25,007,900 | 5.2% |
| Modular Medical, Inc. | February 14, 2024 | 2,110,260 | 10.0% |
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-26 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.